Subretinal Macugen® for Neovascular Age-Related Macular Degeneration

Clinical trial NCT00788177 · UNKNOWN

Trial details

NCT number: NCT00788177
Sponsor: Klinikum Ludwigshafen
Status: UNKNOWN
Phase: Phase 3
Study type: INTERVENTIONAL

Age-related Macular Degeneration

Start date: 2008-11-01
Primary completion: 2012-03-01
Enrollment: 10

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.